- KR₩1tn
- KR₩1tn
- KR₩83bn
Brief: Lunit Inc To Conduct Capital Increase Of 250 Billion Won
Brief: Lunit Announces Collaboration with Daiichi Sankyo on AI-Driven Biomarker Discovery
Brief: Lunit Inc - Awarded National Tender In France For Breast AI
Brief: Lunit Expands Partnership With Saudi Arabia's Largest Medical Group To Deploy Ai Chest X-Ray Solution
Brief: Lunit Shows Promise Of AI In Predicting Immunotherapy Response For Rare Cancer Patients At SITC 2024
Brief: Lunit Completes Acquisition Of Volpara Pioneering Next-Level Of AI-Driven Cancer Care
Brief: Volpara Health Technologies Says Got Initial Court Orders For Scheme Of Arrangement By Lunit
Brief: Lunit AI Solutions To Power Samsung's X-Ray Devices For Advanced Chest Screening
Brief: Lunit To Acquire 253 Billion Won Worth Of Shares And 100% Stake In New Zealand-Based Company Volpara Health Technologies
Australia's Volpara Health Technologies posts record intraday jump on takeover deal
Brief: Lunit Secures $150 Million In Capital Increase
Brief: Lunit Received U.S. Food And Drug Administration (FDA) 510(K) Clearance
Brief: Lunit Enters Into Research Collaboration To Explore The Use Of AI To Improve The Effectiveness Of Immunotherapy
Brief: Lunit Participates In Saudi Vision 2030 Healthcare Sandbox
Brief: Lunit To Conduct Capital Increase Of 202 Billion Won
Brief: Lunit Inc - Collaboration With National Cancer Center Hospital East To Evaluate & Validate Its AI Pathology Solution For Tissue Data Analysis
Brief: Lunit Meets Mdr CE Requirements For 3D Breast Tomosynthesis Ai Solution
Brief: Randomized Controlled Trial Backs Clinical Efficacy Of Lunit AI For Chest X-Ray
Brief: Guardant Health To Integrate Lunit's Ai-Based Scoring Algorithm For Pd-L1 Into Its Portfolio